Academic Thoracic Oncology Medical Investigators Consortium
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Academic Thoracic Oncology Medical Investigators Consortium sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Academic Thoracic Oncology Medical Investigators Consortium: 3 sponsored US clinical trials, none currently recruiting.
Academic Thoracic Oncology Medical Investigators Consortium sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pancreas Ductal Adenocarcinoma, with 1 trials.
Upper-quartile sponsor footprint
Academic Thoracic Oncology Medical Investigators Consortium sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer
NCT03542877
A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients
NCT02879617
Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates
NCT02723331
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
Therapeutic Areas
How the Academic Thoracic Oncology Medical Investigators Consortium early-phase archive is shaped
3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Pancreas Ductal Adenocarcinoma (1 trial), 4 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Academic Thoracic Oncology Medical Investigators Consortium: archived-pipeline peers nationwide
Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Academic Thoracic Oncology Medical Investigators Consortium sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 archived trials
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
- 3EO Health · 0% recruiting · 2 trials
Related
What to do with this Academic Thoracic Oncology Medical Investigators Consortium page
3 registered trials is a research-attention snapshot, not an endorsement of Academic Thoracic Oncology Medical Investigators Consortium or any single study.
- None of Academic Thoracic Oncology Medical Investigators Consortium's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Pancreas Ductal Adenocarcinoma is the condition Academic Thoracic Oncology Medical Investigators Consortium studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pancreas Ductal Adenocarcinoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Academic Thoracic Oncology Medical Investigators Consortium pipeline card: 3 registered trials from official public datasets.Report a data error.